About the Company
omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OMER News
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hidden gems often remain undiscovered within the labyrinth of ...
Investors Profit From Avenue Therapeutics Inc (NASDAQ: ATXI) 9.29% Gain
Avenue Therapeutics Inc (NASDAQ:ATXI) traded at $0.15 at close of the session on Monday, February 26, made an upward move of 9.29% on its previous day’s price. Looking at the stock we see that its ...
Loading the latest forecasts...